Trial Search
Current Search Criteria:
Effect of Acupressure on Constipation in Community-dwelling Spinal Cord Injury Patients: a Randomized Controlled Trial
NASpinal cord injury is a multi-sensory, motor and autonomic dysfunction, cau...
Status
Completed
Location
School of Nursing, The Hong Kong Polytechnic Unviersity
Start Date
2023-03-01
Trial ID
NCT05558657
BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia
PHASE2RATIONALE: The BL22 immunotoxin can locate tumor cells and kill them withou...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2003-10
Trial ID
NCT00074048
Treatments Being Tested
Bladder Meridian Gua Sha for Lumbar Disc Herniation: Efficacy and CRP Regulation Via Cutaneous-Meridian-Visceral Axis in Shen Period
NABased on the "Cutaneous Region-Meridian-Visceral" axis theory, in this stud...
Status
Completed
Location
Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Start Date
2023-01-17
Trial ID
NCT07754422
Retreatment Protocol for BL22 Immunotherapy in Relapsed or Refractory Hairy Cell Leukemia
PHASE2BL22 is a type of protein that scientists have created to interact with cer...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-02
Trial ID
NCT00924040
Treatments Being Tested
Acupuncture and Insulin Doses in Insulin-treated Type 2 Diabetes
NAThis study is a randomized, single blinded, cross-over interventional study...
Status
Unknown
Location
Diabetologia AOU Careggi
Start Date
2019-08-01
Trial ID
NCT04076800
Treatments Being Tested
BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
PHASE1RATIONALE: BL22 immunotoxin can locate tumor cells and kill them without ha...
Status
Suspended
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2004-01
Trial ID
NCT00077493
BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma
PHASE1RATIONALE: BL22 immunotoxin can find tumor cells and kill them without harm...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2005-06
Trial ID
NCT00126646
Treatments Being Tested
Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia
PHASE1RATIONALE: An immunotoxin can locate cancer cells and kill them without har...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
1998-12
Trial ID
NCT00021983
Treatments Being Tested
BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
PHASE1RATIONALE: The BL22 immunotoxin can locate tumor cells and kill them withou...
Status
Withdrawn
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
TBD
Trial ID
NCT00024115
Treatments Being Tested